Azafaros

Developer of small molecule based therapeutics for the treatment of rare metabolic disorders

placeLeiden, South Holland, Netherlands calendar_todayFounded 2018 groups17 employees language azafaros.com

Social engagement

Social engagement: 3.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Forbion, BioGeneration Ventures, Jeito.

Investor typeCountShare
Venture capital675%
Other / undisclosed225%

Recent activity

30 Jun 2026
Event
Annual Symposium of the British Inherited Metabolic Disease Group (#BIMDG)
26 Jun 2026
Recognition
22 Jun 2026
Event
BIO International Convention
Coming soon